Intestinal Research

IBD
The incidence and risk factors of venous thromboembolism in Japanese inpatients with inflammatory bowel disease: a retrospective cohort study: Katsuyoshi Ando, Mikihiro Fujiya, Yoshiki Nomura, Yuhei Inaba, Yuuya Sugiyama, Takuya Iwama, Masami Ijiri, Keitaro Takahashi, Kazuyuki Tanaka, Aki Sakatani, Nobuhiro Ueno, Shin Kashima, Kentaro Moriichi, Yusuke Mizukami, Toshikatsu Okumura; Intest Res. 2018;16(3):416-425. Published online July 27, 2018; DOI: https://doi.org/10.5217/ir.2018.16.3.416
Web of Science 22 Crossref 25; Full text PubReader ePub PDF

The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases: Santosh Sanagapalli, Yanna Ko, Viraj Kariyawasam, Siew C Ng, Whitney Tang, Hithanadura Janaka de Silva, Minhu Chen, Kaichun Wu, Satimai Aniwan, Ka Kei Ng, David Ong, Qin Ouyang, Ida Hilmi, Marcellus Simadibrata, Pises Pisespongsa, Saranya Gopikrishna, Rupert W Leong,; Intest Res. 2018;16(3):409-415. Published online July 27, 2018; DOI: https://doi.org/10.5217/ir.2018.16.3.409
Web of Science 3 Crossref 2; Full text PubReader ePub PDF

Immunohistochemical differentiation between chronic enteropathy associated with SLCO2A1 gene and other inflammatory bowel diseases: Satoko Yamaguchi, Shunichi Yanai, Shotaro Nakamura, Keisuke Kawasaki, Makoto Eizuka, Noriyuki Uesugi, Tamotsu Sugai, Junji Umeno, Motohiro Esaki, Takayuki Matsumoto; Intest Res. 2018;16(3):393-399. Published online July 27, 2018; DOI: https://doi.org/10.5217/ir.2018.16.3.393
Web of Science 15 Crossref 17; Full text PubReader ePub PDF

β-(1,3)-Glucan derived from Candida albicans induces inflammatory cytokines from macrophages and lamina propria mononuclear cells derived from patients with Crohn's disease: Kiyoto Mori, Makoto Naganuma, Shinta Mizuno, Hiroaki Suzuki, Mina T. Kitazume, Katsuyoshi Shimamura, Sayako Chiba, Akira Sugita, Katsuyoshi Matsuoka, Tadakazu Hisamatsu, Takanori Kanai; Intest Res. 2018;16(3):384-392. Published online July 27, 2018; DOI: https://doi.org/10.5217/ir.2018.16.3.384
Web of Science 5 Crossref 5; Full text PubReader ePub PDF Supplementary Material

Delineating inflammatory bowel disease through transcriptomic studies: current review of progress and evidence: Seow-Neng Chan, Eden Ngah Den Low, Raja Affendi Raja Ali, Norfilza Mohd Mokhtar; Intest Res. 2018;16(3):374-383. Published online July 27, 2018; DOI: https://doi.org/10.5217/ir.2018.16.3.374
Web of Science 10 Crossref 10; Full text PubReader ePub PDF

Tumor
Impact of microbiota in colorectal carcinogenesis: lessons from experimental models: Linda Chia-Hui Yu, Shu-Chen Wei, Yen-Hsuan Ni; Intest Res. 2018;16(3):346-357. Published online July 27, 2018; DOI: https://doi.org/10.5217/ir.2018.16.3.346
Web of Science 40 Crossref 40; Full text PubReader ePub PDF

Intestinal microbiota, chronic inflammation, and colorectal cancer: Chan Hyuk Park, Chang Soo Eun, Dong Soo Han; Intest Res. 2018;16(3):338-345. Published online July 27, 2018; DOI: https://doi.org/10.5217/ir.2018.16.3.338
Web of Science 65 Crossref 64; Full text PubReader ePub PDF

Miscellaneous
Efficacy and tolerability of methotrexate therapy for refractory intestinal Behçet's disease: a single center experience: Jihye Park, Jae Hee Cheon, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim; Intest Res. 2018;16(2):315-318. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.315
Web of Science 7 Crossref 9; Full text PubReader ePub PDF

IBD
Comparison of efficacy of once daily multimatrix mesalazine 2.4 g/day and 4.8 g/day with other 5-aminosalicylic acid preparation in active ulcerative colitis: a randomized, double-blind study: Haruhiko Ogata, Tadashi Yokoyama, Seiichi Mizushima, Atsushi Hagino, Toshifumi Hibi; Intest Res. 2018;16(2):255-266. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.255
Web of Science 7 Crossref 8; Full text PubReader ePub PDF Supplementary Material

Microbiota
Characterization of the fecal microbiota differs between age groups in Koreans: Sun-Young Kook, Yunjeong Kim, Ben Kang, Yon Ho Choe, Young-Ho Kim, Seokjin Kim; Intest Res. 2018;16(2):246-254. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.246
Web of Science 6 Crossref 7; Full text PubReader ePub PDF Supplementary Material

IBD
Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies: Satoshi Motoya, Mamoru Watanabe, Hyo Jong Kim, Young Ho Kim, Dong Soo Han, Hirotoshi Yuasa, Junichi Tabira, Naoki Isogawa, Shoko Arai, Isao Kawaguchi, Toshifumi Hibi; Intest Res. 2018;16(2):233-245. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.233
Web of Science 20 Crossref 19; Full text PubReader ePub PDF Supplementary Material

Trough level of infliximab is useful for assessing mucosal healing in Crohn's disease: a prospective cohort study: Akihiro Koga, Toshiyuki Matsui, Noritaka Takatsu, Yasumichi Takada, Masahiro Kishi, Yutaka Yano, Takahiro Beppu, Yoichiro Ono, Kazeo Ninomiya, Fumihito Hirai, Takashi Nagahama, Takashi Hisabe, Yasuhiro Takaki, Kenshi Yao, Hirotsugu Imaeda, Akira Andoh; Intest Res. 2018;16(2):223-232. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.223
Web of Science 9 Crossref 9; Full text PubReader ePub PDF Supplementary Material

Characteristics and management of patients with inflammatory bowel disease between a secondary and tertiary hospitals: a propensity score analysis: Ki Hwan Song, Eun Soo Kim, Yoo Jin Lee, Byung Ik Jang, Kyeong Ok Kim, Sang Gyu Kwak, Hyun Seok Lee,; Intest Res. 2018;16(2):216-222. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.216
Web of Science 2 Crossref 2; Full text PubReader ePub PDF

Evidence-based consensus on opportunistic infections in inflammatory bowel disease (republication): Intest Res. 2018;16(2):178-193. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.178
Web of Science 14 Crossref 17; Full text PubReader ePub PDF

Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis: Kosaku Nanki, Shinta Mizuno, Katsuyoshi Matsuoka, Keiko Ono, Shinya Sugimoto, Hiroki Kiyohara, Mari Arai, Moeko Nakashima, Kozue Takeshita, Keiichiro Saigusa, Mitsutoshi Senoh, Tadashi Fukuda, Makoto Naganuma, Haru Kato, Wataru Suda, Masahira Hattori, Takanori Kanai; Intest Res. 2018;16(1):142-146. Published online January 18, 2018; DOI: https://doi.org/10.5217/ir.2018.16.1.142
Web of Science 5 Crossref 6; Full text PubReader ePub PDF

Funded articles